Clinical Trial Update: Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines [Phase 1]

View source ↗

Summary

Phase 1 trial updating the addition of BAY 1895344 to FOLFIRI in patients with advanced or metastatic colorectal, gastric, and gastroesophageal junction cancers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• BAY 1895344 (BAY 1895344)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING